Evolution Wealth Advisors, LLC Harmony Biosciences Holdings, Inc. Transaction History

Evolution Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$34.09 - $43.91 $3,647 - $4,698	-107 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$25.68 - $38.61 $4,750 - $7,142	-185 Reduced 63.36%	107 $4,000
Q2 2021 Jul 22, 2021	BUY	$25.96 - $33.44 $856 - $1,103	33 Added 12.74%	292 $8,000
Q1 2021 Apr 20, 2021	BUY	$27.56 - $40.37 $413 - $605	15 Added 6.15%	259 $9,000
Q4 2020 Feb 02, 2021	BUY	$31.74 - $51.34 $7,744 - $12,526	244 New	244 $9,000

243

45.2M

108K

49.2K

Ticker HRMY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,161,400
Market Cap $2.05B
Description
Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.